|
Volumn 99, Issue 4, 2000, Pages 255-260
|
Science, art and drug discovery: A personal perspective
|
Author keywords
cGMP; Clinical trials; Combinatorial chemistry; Drug discovery; Erectile dysfunction; Food and Drugs Administration approval; Genomics; High throughput screening; Nitric oxide; Pharmacogenetics; Phosphodiesterases 5; Sildenafil (Viagra ); Target validation
|
Indexed keywords
CYCLIC GMP;
ISOENZYME;
NITRIC OXIDE;
PHOSPHODIESTERASE INHIBITOR;
PYRAZOLOPYRIMIDINE DERIVATIVE;
SILDENAFIL;
ZAPRINAST;
BLOOD FLOW;
CARDIOVASCULAR EFFECT;
COMPUTER MODEL;
CONFERENCE PAPER;
DRUG APPROVAL;
DRUG DESIGN;
DRUG POTENCY;
DRUG RESEARCH;
ERECTILE DYSFUNCTION;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
PRIORITY JOURNAL;
STRUCTURE ACTIVITY RELATION;
TECHNOLOGY;
|
EID: 0033787344
PISSN: 01435221
EISSN: None
Source Type: Journal
DOI: 10.1042/cs0990255 Document Type: Conference Paper |
Times cited : (76)
|
References (15)
|